🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsCompounding & FormulationState pharmacy board compounding enforcement actions — 2026 tracker Page 5

State pharmacy board compounding enforcement actions — 2026 tracker

AttorneyGrant Mon, Feb 16, 2026 at 6:13 AM 26 replies 775 viewsPage 5 of 6
NurseLeah_Nash
Member
278
1,234
Sep 2024
Nashville, TN
Feb 16, 2026 at 1:18 PM#21

Congrats AttorneyGrant!! Keep going — you're doing incredible. 🎉

31 7RegAffairsDC, BiostatsBrad, PeptideSynthNJ and 28 others
Reply Quote Save Share Report
mia_MS2
New Member
8
23
Mar 2026
Ann Arbor, MI
Feb 16, 2026 at 1:35 PM#22

Reading this thread on State pharmacy board hits close to home. Night shift nurse — I started at 263 lbs and felt like I would tried everything.

9 months on tirz and I am a different person. Not just the 38 lbs lost — my energy, my mood, my relationship with food. All transformed.

If you are on the fence about State pharmacy board — take the leap. It was the best health decision I have ever made. ❤️

Last edited: Feb 16, 2026 at 4:35 PM
25 18FDA_TrackerJim, ricardo_MIA, BrianDallas92 and 22 others
Reply Quote Save Share Report
EndoResFellow
Member
456
2,345
Sep 2024
Baltimore, MD
Feb 16, 2026 at 1:52 PM#23

As a pharmacist, I want to add some clinical context to this discussion on State pharmacy board compounding.

Building on what NurseLeah_Nash said — the evidence base here is robust. The key publications to reference are from the FLOW program[1].

Key clinical points:

  1. Efficacy is dose-dependent and typically requires 4-5 weeks to reach steady state
  2. Side effect profile is predictable and usually manageable with standard protocols
  3. Monitoring should include baseline labs and follow-up at 3-month intervals
  4. Patient education significantly improves outcomes and adherence

Standard disclaimer: this is educational, not individualized medical advice.

References:
[1] See thread title for relevant study identification.
Last edited: Feb 16, 2026 at 3:52 PM
1 9paul_denver
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
AussieAnna
Member
678
2,890
Jun 2024
Sydney, AU
Feb 16, 2026 at 2:09 PM#24

mia_MS2 — wow. I've been looking for this exact info for weeks.

Last edited: Feb 16, 2026 at 3:09 PM
21 13bri_stats, pete_manc_UK, anna.melb_AU and 18 others
Reply Quote Save Share Report
Dr.AddMedPHL
Senior Member
1,234
6,234
Mar 2024
Philadelphia, PA
Feb 16, 2026 at 2:26 PM#25

Adding my data to this State pharmacy board discussion:

MetricBaselineMonth 5Month 6
Weight256 lbs246 lbs221 lbs
A1C7.0%6.0%5.2%
hsCRP5.04.00.6

Protocol: Semaglutide 1.7mg/wk, resistance training 3x/wk, protein 1.3g/kg/day.

33 18JessicaM_2024, TomFromTexas, mike.trainer_LA and 30 others
Reply Quote Save Share Report

Similar Threads

503A vs 503B compounding — regulatory framework explained4 replies
Compounded semaglutide stability: accelerated degradation study results6 replies
Lyophilized vs liquid peptides — stability and bioavailability comparison18 replies
Bacteriostatic water sourcing and sterility considerations8 replies
State-by-state compounding pharmacy regulations — 2026 map8 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register